Kathleen Laporte 89bio, Inc. (ETNB) insider trading activity

Kathleen Laporte is of 89bio, Inc.. Currently has a direct ownership of 0 shares of ETNB, which is worth approximately $0. The most recent transaction as insider was on Jul 17, 2023, when has been sold 12,500 shares (Common Stock) at a price of $18.8 per share, resulting in proceeds of $235,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

n/a 12M change

Total Value Held $0

KATHLEEN LAPORTE Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Jul 17 2023	SELL Open market or private sale	$235,000 $18.8 p/Share	12,500 Reduced 100.0%	0 Common Stock
Jul 17 2023	BUY Exercise of conversion of derivative security	$33,000 $2.64 p/Share	12,500 Added 50.0%	12,500 Common Stock

Also insider at

PBAXU

PHOENIX BIOTECH ACQUISITION CORP. Financial Services

Director

FIXX

Homology Medicines, Inc. Healthcare

BOLT

Bolt Biotherapeutics, Inc. Healthcare

PRPO

Precipio, Inc. Healthcare

Director